1-2 of 2
Tokihiro Ro
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

An Open-Label, Multicenter, Single-Arm, Phase I Dose Escalation Study of OP-2100, an Orally Bioavailable Prodrug of Decitabine, for Patients with Relapsed or Refractory Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

Shinya Kimura, Kensuke Usuki, Tatsuo Ichinohe, Takayuki Ikezoe, Junya Kuroda, Senji Kasahara, Sho Okamoto, Hiromitsu Iizuka, Hiroshi Ureshino, Tatsuro Watanabe, Tokihiro Ro, Kosuke Endo, Yuka Kagawa, Yuki Kurahashi, Toshiki Naito, Takahiro Yamauchi
Journal: Blood
Blood (2023) 142 (Supplement 1): 6466.
https://doi.org/10.1182/blood-2023-173174
Published: 2023
Journal Articles

Phase I/II Multicenter Study of Romidepsin in Japanese Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma

Michinori Ogura, Dai Maruyama, MD PhD, Kensei Tobinai, MD, PhD, Toshiki Uchida, MD PhD, Kiyohiko Hatake, MD PhD, Masafumi Taniwaki, MD PhD, Kiyoshi Ando, MD PhD, Kunihiro Tsukasaki, MD, Takashi Ishida, MD PhD, Naoki Kobayashi, MD PhD, Kenichi Ishizawa, MD PhD, Yoichi Tatsumi, Koji Kato, MD PhD, Toru Kiguchi, MD PhD, Takayuki Ikezoe, MD PhD, Eric Laille, MS, Tokihiro Ro, MS, Hiromi Tamakoshi, MBA, Sanae Sakurai, MS, Tomoko Ohtsu, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3012.
https://doi.org/10.1182/blood.V128.22.3012.3012
Published: 2016